Mindfulness Intervention for People With Psychosis

NCT ID: NCT03501862

Last Updated: 2021-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-15

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

People with psychosis demonstrated a tendency to use maladaptive cognitive emotion regulation strategies as compared with healthy control groups.

The present study is the first randomized controlled trial of group mindfulness-based intervention for psychosis. Half group will join the mindfulness-based cognitive intervention while another half will participate in psychoeducation to examine whether mindfulness will have a positive impact on emotion regulation and distress.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Concurrently with positive and negative symptoms, affective symptoms and full affective disorder episodes are common in psychotic disorders particularly in the acute phase of illness.

Affective symptoms are a significant risk factor accounting for approximately 5-6% of suicide rates which remain or becomes higher shortly after a psychotic episode or hospital discharge (American Psychiatric Association, 2013). It has been proved that the emotion management and cognitive reappraisal were negatively associated with schizophrenia.

In the study, it is hypothesized that the intervention will have a positive impact on psychotic symptoms, general symptoms such as affective symptoms, psychological flexibility, mindfulness skills, quality of life and re-hospitalization by facilitating strategies on emotion regulation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Recent-onset Psychosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants referred to the study will be assessed at a screening examination to ensure eligibility and obtain written consent by a research assistant. Eligible participants will undertake a further interview on outcome measures prior to randomization within 3 weeks the commencement of intervention.

Eligible participants will be randomly assigned to receive Mindfulness-based Cognitive Therapy for Psychosis (MBCTp) plus TAU or TAU plus Psychoeducation for Psychosis (PEp).

Simple randomization will be used to ensure that participants will have equal opportunity to be included into the study (Altaman and Bland, 1999).
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Assignment to the study groups will be made independently of staff involved in the recruitment and management of participants in the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mindfulness-based intervention

Intervention: a twelve 1.5 weekly program on mindfulness-based cognitive therapy (psychosis)

Group Type EXPERIMENTAL

Mindfulness-based cognitive therapy (psychosis)

Intervention Type BEHAVIORAL

A small group intervention is based on a structured and validated protocol that will include mindfulness practice, cognitive skills

Psychoeducation

Intervention: a twelve 1.5 hours weekly program on psychoeducation (psychosis)

Group Type ACTIVE_COMPARATOR

Psychoeducation (psychosis)

Intervention Type BEHAVIORAL

A small group intervention will be focusing on understanding of psychosis, treatment, relapse prevention and useful information and resources.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mindfulness-based cognitive therapy (psychosis)

A small group intervention is based on a structured and validated protocol that will include mindfulness practice, cognitive skills

Intervention Type BEHAVIORAL

Psychoeducation (psychosis)

A small group intervention will be focusing on understanding of psychosis, treatment, relapse prevention and useful information and resources.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be Chinese residents and aged above 18
* Have a primary diagnosis of psychosis (non-affective) and/or other psychotic disorders met the Diagnostic and Statistical Manual DSM-5
* Have been diagnosed equivalent to or less than 5 years
* Mentally stable as assessed by the researcher and a psychiatrist to comprehend the education and training provided (a pre-recruitment briefing session for potential participants will be conducted to verify their ability to follow instructions and understanding in participation, and case files will be reviewed to ensure a stable medication regime for at least 6 months) in order to ensure their ability to make a valid consent
* Able to read and understand Chinese

Exclusion Criteria

* Have recently participated in (less than 3 months) or are receiving other structured psycho-education and/or psychotherapies
* Have comorbidities (a) developmental impairment (b) learning disability, (c) personality disorders, and/or (d) any clinically significant medical diseases (by case-file review).
* Have organic psychosis or a primary drug or alcohol addiction
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Edinburgh Napier University

OTHER

Sponsor Role collaborator

The Hong Kong Polytechnic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

YIP Lai King

Senior Clinical Associate

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thanos Karatzias

Role: STUDY_DIRECTOR

Edinburgh Napier University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Fourth People's Hospital

Chengdu, , China

Site Status

The Society of Rehabilitation and Crime Prevention

Hong Kong, , Hong Kong

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China Hong Kong

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSEARS20170811001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

mHealth for Psychosis Help-seeking
NCT05905601 COMPLETED NA